Introduction Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are risk factors for hepatocellular carcinoma, a type of primary liver cancer, and are most prevalent in people born . Relatively little information is available for liver cancer prevention, compared to other cancers. In this review, we provide a summary of current promising public health practices for liver cancer prevention from the literature, as well as liver cancer-related initiatives in the National Comprehensive Cancer Control Program (NCCCP). Methods Two types of source materials were analyzed for this review: published literature (2005-present), and current cancer plans from the NCCCP (2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017)(2018)(2019)(2020)(2021)(2022). A search strategy was developed to include a review of several scientific databases. Of the 73 articles identified as potentially eligible, 20 articles were eligible for inclusion in the review. Eligible articles were abstracted using a data abstraction tool. Three independent keyword searches on 65 NCCCP plans were conducted. Keyword searches within each of the plans to identify activities related to liver cancer were conducted. Relevant information was abstracted from the plans and saved in a data table. Results Of the 20 eligible articles, 15 articles provided information on interventions related to liver cancer and hepatitis B or hepatitis C prevention. All 15 of the intervention articles were related to hepatitis; 13 were hepatitis B-focused, two were hepatitis C-focused, and 14 focused on Asian/Pacific Islander American populations. The independent keyword search of NCCCP plans produced 46 results for liver, 27 results for hepatitis, and 52 results for alcohol. Two plans included activities related to liver cancer. Twenty-four plans included activities related to hepatitis. Discussion A majority of the intervention articles published focused on HBV infection in Asian/Pacific Islander American populations, and a small percentage of NCCCP plans included liver-related content. The findings from this review will inform the development of an Action Plan on liver cancer prevention for the NCCCP, which will assist programs with the adoption and uptake of promising practices for the prevention of liver cancer.
Introduction
Worldwide, liver cancer is the fifth most common cancer among men, the ninth most common cancer among women, and the second most common cause of cancer death for men and women combined [1] . In the United States, each year approximately 31,000 new cases of liver cancer are diagnosed and almost 25,000 people die from the disease [2] . Liver cancer is more common in men than women, and among Asian/Pacific Islander, Hispanic, and American Indian/Alaska Native populations compared with other racial and ethnic groups [2] . The five-year net survival rate Disclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
for liver cancer is 14.8% [3] . Liver cancer incidence has been increasing in the United States since the mid-1970s [4] . A major factor contributing to the increase in hepatocellular carcinoma (HCC), the most common type of liver cancer, is a high prevalence of chronic hepatitis C virus (HCV) infection among "baby boomers," or those born during 1945 through 1965 [4] . Increases in obesity and type II diabetes over the past several decades have also likely contributed to the increasing liver cancer trend, because of their association with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) [5] . Other notable risk factors for development of HCC include chronic infection with hepatitis B virus (HBV) and alcoholic cirrhosis [6] .
Due to recent advances in treatment, hepatitis C is now curable with short and easily tolerable courses of treatment [7] . Most cases of HBV infection can be prevented through vaccination [8] . The extent to which these preventive interventions are adopted within populations is unclear. The Centers for Disease Control and Prevention's (CDC) National Comprehensive Cancer Control Program (NCCCP) is well positioned to raise awareness of the growing incidence of liver cancer, and the critical role prevention efforts can play in reducing future incidence and liver cancer-related morbidity and mortality. Recipients of NCCCP funding develop specific plans to address the burden of cancer in their population. Current recipients of funding include all 50 states, the District of Columbia, and several tribes and territories [9] .
In 2010, a review of NCCCP plans for liver cancer prevention activities revealed that most plans did not address the connection between chronic HBV and/or HCV infections and liver cancer, and only a few plans mentioned prevention activities to reduce the burden of liver cancer [10] . In order to increase uptake and identify liver cancer prevention activities that can be included in NCCCP plans for the broader cancer control community, we undertook a review of the current literature related to public health liver cancer prevention efforts to inform the NCCCP, and also conducted an updated review of NCCCP plans. The findings from this review will inform the development of an Action Plan on liver cancer prevention for the NCCCP, which will assist programs and the cancer community with the adoption and uptake of relevant, non-clinical, promising practices for the prevention of liver cancer.
Methods

Data sources
Published literature
For the review of published literature, we developed a strategy to search several scientific databases, including PubMed and EBSCOhost (which included 17 databases within EBSCO), for interventions within the scope of NCCCP capabilities. Table 1 lists the search terms and phrases used  for the published literature. We used a two-step process to determine final eligibility for inclusion in this review. First, we reviewed article abstracts to determine if they were (1) published in English; (2) published in peer-reviewed publications including government reports, reviews, dissertations, and conference abstracts; (3) published between 2005 and 2015; and (4) focused on research-tested interventions (non-clinical) or promising practices, strategies, or activities related to liver cancer prevention or hepatitis B/hepatitis C prevention that would serve to inform the work of the NCCCP and broader cancer control community.
Because the objective of our review is to increase adoption of practices within the NCCCP and the broader cancer control community, the setting for eligible intervention studies was also restricted to the geographic areas where NCCCP-supported programs are located (states, tribes, and territories). Based on this preliminary review, if an abstract met all the eligibility requirements, we reviewed and abstracted the full article. Of the 73 articles identified as potentially eligible, 20 articles were eligible for inclusion in this review. It is important to note that if an article was not directly tied to the prevention of liver cancer, it was excluded from further review. All eligible articles were abstracted using a data abstraction tool that included data points (topic, citation, study description, article focus, study year, study design, study sample, intervention type, outcomes, etc.) for abstraction and a description of those data points. Following abstraction, we grouped the articles in seven relevant topic areas. Table 2 provides details on the number of articles based on eligibility within each topic. Three investigators were each assigned, and responsible for abstracting data from a unique subset of the 20 eligible articles. One of the three investigators reviewed data abstracted across all articles for accuracy.
NCCCP plans
NCCCP plans are publicly available and were obtained from the CDC website at https ://www.cdc.gov/cance r/ncccp /index .htm using the search tool available on the website, we conducted three independent keyword searches for the terms liver, hepatitis, and alcohol of all 65 NCCCP plans currently available on the website. We conducted subsequent keyword searches within each of the individual 65 plans to identify goals, strategies, objectives, activities, and other elements related to liver cancer within each plan. Relevant information was abstracted from the plans. All searches were done by one investigator and content abstracted was reviewed for accuracy by all investigators.
Results
Published literature
Of the 20 eligible articles, four were systematic reviews, one primarily provided recommendations, and 15 described specific interventions or programs related to hepatitis B, hepatitis C, or liver cancer prevention. The four systematic reviews were published between 2012 and 2015 [11] [12] [13] [14] and one [15] was a "report and recommendation article" published in CDC's Morbidity and Mortality Weekly Report. Of the 15 intervention articles (Table 3) , 13 focused on hepatitis B, two focused on hepatitis C, and 14 focused on Asian/Pacific Islander American populations [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . None of these articles were related to alcohol or NAFLD/NASH, discussed baby boomers, people in urban areas, or areas with high rates of intravenous drug use.
Surveillance
Surveillance was discussed in the systematic reviews and recommendations article, but not in the intervention articles. One study emphasized the importance of investing in surveillance of hepatitis B and hepatitis C to guide prevention efforts. In addition to reporting to health departments, Perez et al. recommended that hepatitis B and hepatitis C surveillance include identifying persons requiring counseling and linkage to care [14] . Similarly, Meyers et al. reported that primary care settings located in clinics serving homeless persons, or people who inject drugs, represent key opportunities for hepatitis C care linkage interventions [12] . They also indicated that once patients are successfully diagnosed, linked to care, and initiated on treatment, adherence to medication therapy needs to be optimized [12] . Meyer et al. [12] recommend strategic incorporation of evidence-based interventions into hepatitis C treatment implementation efforts to most effectively deliver treatment and maximize treatment outcomes.
Other studies described in the systematic reviews also recommended development of surveillance registries for HBV infection. These registries can facilitate the notification, counseling, and medical management of persons with chronic HBV infection [15] . Registries can include the following elements: (1) demographic characteristics; (2) serologic test results; (3) ethnicity and/or country of birth; (4) information about contacts identified and managed; and (5) medical referrals made [15] . 
Knowledge and awareness
Fifteen articles described knowledge and awareness interventions and provided information on primary and/or secondary outcomes. The majority of these interventions (n = 12) described interventions that were culturally and linguistically tailored for Asian American populations. They included lay health worker interventions, community-based outreach programs, health education interventions, electronic health record (EHR) prompts, faith-based interventions, and mass media campaigns. Three of the eligible studies [16, 19, 30] described interventions developed using the Health Behavior Framework, [31] which represents a synthesis of several of the major health behavior change theories. The framework guided the development of data collection instruments and intervention design and implementation. One study [27] described the intervention components from four studies [16, 19, 30] that were used to promote hepatitis B testing. These studies primarily focused on modifying individual (e.g., knowledge, health beliefs, patientprovider communication) and community level (e.g., social norms) factors of the Health Behavior Framework [27] . These studies described the type and degree of modification necessary to culturally tailor the intervention approaches and messages [27] .
Improvements in knowledge of hepatitis B or hepatitis C and screening behaviors were also commonly observed among intervention participants. Increases in knowledge were typically assessed through self-report questionnaires and were reported in five of the eligible studies [19, 20, [28] [29] [30] . One study reported an experimental lay health worker group was more likely than the control group to know that Cambodian Americans have higher rates of HBV infection than whites, HBV cannot be spread by eating food prepared by an infected person, HBV cannot be spread by sharing chopsticks, and HBV cannot be spread by shaking hands [30] . Another study that offered a lay health worker intervention for Hmong Americans found statistically significant differences (mean knowledge score gain between pre-tests and post-tests) detected in 6 out of 11 hepatitis B-related knowledge items for the intervention group (e.g., one cannot get HBV infection by sharing food/eating utensils, Hmong are more likely than white Americans to be infected with HBV), compared to only 1 item for the control group (HBV causes liver cancer) [19] . A study that examined the impact of delivering lecture-based, community hepatitis B education found that all eight participating Asian groups had statistically significantly improved knowledge of hepatitis B and its transmission at post-test compared to a pre-test [20, 21] .
Two literature reviews provided three recommendations for developing effective patient and provider education programs. Perez et al. made a recommendation to develop and/ or disseminate health education programs for the general public, high-risk populations, and decision makers. This can be accomplished through awareness campaigns, health communication activities, and community outreach to promote education and knowledge about the risk factors, prevention, and transmission of HCV, importance of testing and counseling, medical management of the condition to prevent chronic liver disease, and identification of facilities that offer integrated care and service delivery for infected individuals Chao et al. [18] Asian Americans Increased HBV awareness, testing, follow-up with physician 4.
Chen et al. [19] Hmong Americans Increased HBV testing 5.
Hsu et al. [20] Asian Americans Increased HBV knowledge, testing, and awareness of disease status 6.
Hsu et al. [21] Asian Americans Increased knowledge of HBV prevention 7.
Hsu et al. [22] Asian Americans Increased HBV testing 8.
Juon et al. [23] Asian Americans Increased HBV testing and vaccination 9.
Juon et al. [24] Asian Americans Increased HBV testing 10. Ma et al. [25] Vietnamese Americans Increased HCV testing and knowledge 11. Marineau et al. [26] Filipino Americans Increased HBV knowledge, testing, and awareness of disease status 12. Maxwell et al. [27] Asian Americans Increased HBV testing 13. Norton et al. [28] Participants at homeless shelters, drug rehabilitation centers, women's centers
Increased knowledge of HCV; improved attitudes toward HCV screening 14. Taylor et al. [29] Chinese Americans Increased HBV knowledge and testing 15. Taylor et al. [30] Cambodian Americans Increased HBV knowledge and testing [14] . Another recommendation from Perez et al. was to create a professional training program for health care and social service providers regarding the prevention, detection, and medical management of persons infected with HCV, HBV, and HIV in order to help them deliver better services to infected patients [14] . Lastly, patient education can be conducted in a culturally sensitive manner in the patient's primary language (both written and oral when possible). Ideally, bilingual, bicultural, and medically trained interpreters could be used when indicated [15] .
Immunization
Two articles described immunization interventions in the context of liver cancer prevention. For those individuals who are susceptible to HBV infection, completion of the vaccination series is the essential step preventing infection.
Immunization could prevent 95% of infections [32, 33] . One of the studies examined factors associated with outcomes of blood screening and infection status among five Asian American group and found that age and race/ethnicity were associated with immunization status. Older persons were more likely to be immunized than younger persons [21] . Compared with the other Southeast Asian groups, Chinese, Korean, and Vietnamese persons were more likely to receive vaccinations than Asian Indians [21] . CDC recommendations state that prior to receiving hepatitis B immunization, most individuals should have their HBV serologies tested to avoid unnecessarily vaccinating individuals who are already chronically infected with HBV, or those who were infected and cleared the virus and are now immune [34] . Chronically infected individuals should be linked to care [34] . Another study [17] provided results from a pilot program that offered free HBV testing with lowcost hepatitis B vaccination. At an annual symposium on hepatitis B prevention and education organized by a local community organization in California, sponsors offered participants free HBV serologic testing; over half were tested [17] . At a follow-up event, 72 participants paid a discounted fee for the hepatitis B vaccine, with the first shot administered on-site and follow-up shots scheduled 1 and 6 months later [17] . Results from this pilot study indicated that out of 1,106 adults tested, 9% were chronically infected with HBV, and 53% were susceptible. Of those who chose to have the hepatitis B or combined hepatitis B/hepatitis A vaccine at their first visit, 87% of unprotected adults and 81% of untested adults completed the hepatitis B vaccination [17] .
Viral hepatitis services
Four articles described viral hepatitis services interventions. A systematic review conducted in 2012 [11] highlighted research findings associated with reducing the development of HCC in patients with HCV-related liver cirrhosis. This involved confining intensive screening and prevention programs to high-risk patients, hepatitis B vaccinations, counseling newly infected patients, testing for HCV in all persons with risk factors for infection, treatment for all HCV-infected persons, and preventing chronic liver disease of any etiology, including alcohol.
Another study assessed the effectiveness of EHR prompts to increase HBV testing in Chinese and Vietnamese patients within an academic health system [22] . A randomized controlled trial conducted for this study in 2011 found that providers ordered hepatitis B surface antigen (HBsAg) tests for 36 out of 88 (40.9%) of the intervention patients, and only 1 out of 87 (1.1%) of the control patients. Results from this study indicate that EHR-based provider prompts significantly increase HBV testing in Chinese and Vietnamese patients when compared to usual care.
Three studies included under knowledge and awareness described educational interventions conducted with a specific Asian subgroup (Korean, Cambodian, and Hmong Americans) to increase the number of individuals who get tested for hepatitis B [16, 19, 30] . Each of the interventions included a culturally relevant educational session that reviewed HBV, liver cancer, and the importance of being tested as well as vaccinated against hepatitis B. One study examined the use of patient navigators to take participants to a healthcare provider for testing, or for follow-up if they tested positive [19] . In all three studies, researchers followed up with participant's 6-month post-intervention and reported that the intervention group was more likely to report receiving a HBV test than the control group.
In addition to hepatitis testing, patients who test positive for HBV or HCV infection should receive appropriate follow-up and treatment services [12, 15] . Primary care settings represent key linkage opportunities, particularly if these practices have ties to populations at high risk for HBV or HCV infection [12, 15] . Additionally, strategies to expand linkages to hepatitis C treatment could include correctional settings, because of the high prevalence of disease and the highly structured nature of a controlled environment; however, this setting is underutilized [12] .
NCCCP plans
The independent keyword search of 65 NCCCP plans identified 59 plans that mentioned one of the three keywords: liver (46 plans), hepatitis (27 plans), and alcohol (52 plans).
Of these 59 plans, 36 were created in 2015 or earlier. Table 4 provides examples of the types of HBV-, HCV-, and alcohol-related activities awardees planned.
We identified 26 NCCCP plans that included specific goals and strategies to address liver cancer prevention and control. The "hepatitis" keyword search yielded 24 plans that included goals, objectives, strategies, or activities; the "liver" keyword search yielded two plans that included goals, objectives, strategies, or activities. Among the 24 plans addressing hepatitis, goals, objectives, and strategies were most commonly framed within the context of infectious diseases or immunization and focused on HBV knowledge and awareness and immunization.
The keyword search using the term "alcohol" yielded 21 plans that included goals, objectives, and strategies related to alcohol. These plans used the framework of healthy lifestyle, eating, or healthy nutrition to focus on reducing consumption beyond recommended levels.
Discussion
Investing in surveillance of hepatitis B and hepatitis C is essential to the prevention of liver cancer, suggesting the need for the NCCCP to continue to help with tracking vaccine uptake, but also identifying those requiring counseling and linking them to care. Although the literature recommends strategic incorporation of evidence-based interventions into hepatitis C treatment implementation efforts, the recommendation did not specify which interventions to implement [12] . Therefore, the NCCCP could be engaged in identifying strategies within their population for retaining people with HCV infection in care even after successful completion of treatment, as well as for continued surveillance of liver cancer (for those with advanced liver disease at the time of hepatitis C treatment) and of reinfection.
The findings focused on the need to modify individual and community level factors of the Health Behavior Framework to promote hepatitis B testing [27] . NCCCPs are actively engaged in increasing knowledge and awareness on hepatitis B vaccination, and improving health professionals' knowledge related to the increased use of the vaccine. However, there is an opportunity for the NCCCP to help with culturally tailoring the intervention approaches and messages for their respective populations. Delivering lecturebased hepatitis B education has been shown to significantly improve knowledge of hepatitis B and its transmission [20, 21] , suggesting that the NCCCP can facilitate the modification of existing educational campaigns to incorporate this promising intervention in their population. Additionally, the development and dissemination of effective patient and provider education programs, and professional training programs to state cancer programs and key clinical staff, is essential in order to help them deliver better services to infected patients. The NCCCP can help implement these programs through the development of awareness campaigns and community outreach initiatives within their population. NCCCPs could ensure that these educational programs promote education and knowledge about the risk factors, prevention, and transmission of HCV, importance of testing and counseling, medical management of the condition to prevent chronic liver disease, and identification of facilities that offer integrated care and service delivery for infected individuals [14] . NCCCPs could also ensure that these educational programs are conducted in a culturally sensitive manner. Additionally, the training programs developed and delivered by NCCCPs could include information on the prevention, detection, and medical management of persons infected with HCV and HBV, in order to help them deliver better services to infected patients [14] .
Hepatitis B vaccination is the most effective way to prevent HCC, the most common type of liver cancer, associated with chronic HBV infection [11] . In 2008, the CDC recommended hepatitis B testing for persons born in countries where HBV infection prevalence is ≥ 2%, which includes much of sub-Saharan Africa and Asia. In 2014, the United States Preventive Services Task Force (USPSTF) also recommended hepatitis B testing for these populations [35] . Therefore, another promising practice for the prevention of infection and liver cancer for those individuals who are susceptible to HBV infection includes completion of the vaccination series. Hsu et al. [21] found that age and race/ ethnicity were associated with immunization status, therefore NCCCP awardees, through a needs assessment, can reach out to those populations that are less likely to receive vaccinations. Providing a discounted fee for the hepatitis B vaccine has been shown to improve completion of the vaccination, [17] suggesting that NCCCPs could partner with local community organizations to offer similar incentives, or promote existing vaccination programs.
In 2017, the National Academies of Sciences, Engineering, and Medicine, published a phase two report on a national strategy for the elimination of hepatitis B and C [7] . In the report, the authors stated that diagnosing 90% of cases, bringing 90% of those to care, and treating 80% of those for whom treatment is indicated, would result in a cumulative 50% reduction in mortality by 2030, averting over 60,000 deaths. The same level of diagnosis, care, and treatment would reduce incident liver cirrhosis by about 45% and new cases of HCC by a third [7] . Thus, NCCCPs can play a critical role in reducing the development of liver cancer in patients with HCV-related cirrhosis by helping to deliver and implement prevention programs to high-risk patients. These programs could include testing for hepatitis C in all persons with risk factors for infection and treatment for all HCV-infected persons. NCCCP-supported programs could expand their primary care partnerships to include local clinics that serve populations at high risk for viral hepatitis infection (e.g., individuals who inject drugs or are homeless) to screen them for hepatitis C and link them to care. The major challenge in scaling up hepatitis C treatment is currently increasing testing to identify those infected and • Implement policy, systems, and environmental change and other evidence-based strategies that address infectious disease causes related to cancer
• Support educational campaigns targeted to at risk adolescents and adults regarding the benefits of HVB vaccine
• Educate high-risk populations, including injection drug users, on how to prevent contracting hepatitis C • Educate high-risk populations, including veterans and baby boomers, on the importance of getting tested for hepatitis C
• Launch hepatitis C prevention campaign • Implement policy, systems, and environmental change and other evidence-based strategies that address infectious disease causes related to cancer
• Promote safer health care practices to reduce exposure of patients and health care workers to hepatitis viruses by enforcement of requirements for safer equipment and injury reporting, reducing needle stick injuries • Train the community (including community leaders and government officials) on the misuse of alcoholl
• Increase awareness of the connection between alcohol consumption and cancer risk
• Educate providers on how to counsel patients regarding negative health effects of excessive and binge drinking
• Increase efforts targeting community and government leaders to increase awareness of societal costs of alcohol use
• Discourage consumption of alcoholic beverages in excess of recommended levels
• Inform the public of the adverse consequences of underage drinking Table 4 (continued reducing payer imposed restrictions to treatment access [36] . NCCCP awardees could develop new or strengthen existing partnerships within their state health departments' hepatitis program so that they can work in a more coordinated manner to reach high-risk individuals and increase their awareness of liver cancer and the need for increased prevention efforts. Risk-based testing guidelines were issued in 1998 by CDC, to recommend hepatitis C testing in persons at high risk for HCV infection, including past or current injection drug users and those in receipt of a blood transfusion before 1992. In 2012, the CDC recommended 1-time hepatitis C testing for individuals born during 1945 through 1965 (i.e., "baby boomer" generation) regardless of ascertainment of other risk factors [37] because of the high prevalence in that population (~ 3% vs. ~ 1% in the general populations). The following year, the USPSTF issued similar recommendations [38] . These populations were targeted because there is evidence of an increased burden of HCV infection and liver cancerassociated mortality among this birth cohort. Even though baby boomers' risk is elevated, a 2013 National Health Interview Survey indicated that only 12.3% reported receiving hepatitis C testing [39] . These recommendations provide a unique opportunity for NCCCP awardees to identify settings appropriate for viral hepatitis vaccination, screening, and treatment in communities, as well as to work with partners and state and local health departments to support standard case finding measures and ensure follow-up and monitoring of people with HBV and HCV infections. Two additional promising practices found in the literature include EHR-based provider prompts and the use of patient navigators. Hsu et al. [22] indicate that EHRbased provider prompts can increase hepatitis B testing in patients when compared to usual care; thus, EHR prompts are a promising intervention that can be utilized by the NCCCPs. Lastly, the use of patient navigators to take participants to a healthcare provider for testing, or for followup if tested positive, is another promising practice that could be adopted by the programs.
This review was subject to several limitations. First, among studies identified in the published and gray literature, some intervention details were missing such as information on the necessary resources needed to implement the intervention successfully. Because this information was missing, we made "informed inferences" about the types of resources necessary for intervention implementation. Second, interventions identified in the published literature focused on the individual level, which may be less relevant to the NCCCP given the program's emphasis on increasing population-based health. Third, there is a lack of generalizability in most of the intervention studies identified in the published and gray literature. Almost all focused on Asian American subpopulations (e.g., foreign-born Chinese adults); and, sample sizes were small. Fourth, our review of the literature focused on public health programs related to liver cancer and may have missed articles more clinical in nature and focused only on specific forms of liver cancer (e.g., HCC). Fifth, we did not control for the limitations of reviewed studies related to research design including reporting bias, selection bias, accuracy, and reliability of identified risk factors, cost and budget limitations, lack of randomization of participants to a non-intervention group to assess the effectiveness of event activities, and incomplete data/loss to follow-up. Sixth, NCCCP plans are updated on different cycles, thus, some plans may not be as recent as other plans. Therefore, our findings may not reflect newer liver cancer prevention and control activities developed or being planned by some NCCCP awardees. Lastly, we did not review grantee progress reports; therefore, information related to grantee progress toward meeting objectives was not assessed.
In conclusion, promising practices in the areas of surveillance, primary prevention through immunization, knowledge and awareness of infection status, and improved viral hepatitis treatment services, have the ability to reverse increasing liver cancer trends. NCCCP awardees are including hepatitis-related activities in their cancer plans; however, there is a need for awardees to diversify their interventions. CDC has supported the development of a number of technical assistance resources in order to assist programs to either begin or build upon their ongoing work. Examples include a viral hepatitis and liver cancer national prevention profile, state-specific prevention profiles, as well as a worksheet to help public health professionals address the burden of viral hepatitis, all of which can be found on the CDC liver cancer website [40] . The findings from this review of published literature and NCCCP plans will inform the development of an Action Plan on liver cancer prevention for the NCCCP. This plan will assist programs with the adoption and uptake of promising practices for the prevention of liver cancer within their respective populations.
